RSS

Newsroom

Minimizing Business Disruption During COVID -Monday, November 23, 2020
Given the unprecedented events of 2020, having a robust business continuity management system (BCMS) in place is more important than ever before.
Qosina is pleased to carry a variety of SmartSite™ swabbable needle-free injection sites.
Qosina Corp. and its beauty division, Qosmedix, are proud to announce they have been awarded a bronze medal for Corporate Social Responsibility from EcoVadis, the world's most trusted provider of business sustainability ratings.
Qosina is pleased to announce they now carry a sterile 3D-printed nasopharyngeal COVID-19 testing swab for nasal mucosa specimen collection.
ISO 80369-7, which specifies dimensions and requirements for the design and performance of small-bore connectors intended to be used in intravascular or hypodermic applications, is currently under revision.
Qosina is pleased to offer 3D-printed nasopharyngeal swabs, plus anterior nares swabs for nasal mucosa specimen collection during COVID-19 testing.
Qosina is pleased to announce they have teamed up with veteran medical adhesive manufacturer H.B. Fuller to offer a selection of off-the-shelf instant and UV-curable cyanoacrylate adhesive solutions for bonding medical device assemblies.
Qosina offers a wide selection of in-stock tubing for prototyping and large-scale production requirements.
Qosina is pleased to co-sponsor Medical Product Outsourcing’s upcoming webinar, “Pandemic Outsourcing: Best Practices and Lessons Learned” on Wednesday, May 27, at 2:00 ET.
In these uncertain times, Qosina understands it is imperative that its customers quickly adapt to the changing needs of the medical device industry.